MKI67 and cancer: A previous study reported that the number of Ki-67-positive cancer cells in resected PDAC tissues was significantly higher in patients treated with neoadjuvant GnP therapy than in those treated with neoadjuvant gemcitabine plus S-1 therapy [59].